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(median age 73 years [interquartile range 61–80], onset-to-
tPA time 129 min [95–152]). Among 24 patients (21%) with 
extensive hypoattenuation on CTASI and extensive throm-
bus burden (combined score  ^  10), only 4% (1/24) were func-
tionally independent whereas mortality was 50% (12/24). In 
contrast, 57% (51/90) of patients with less affected scores 
(combined score 11–20) were functionally independent and 
mortality was 10% (9/90; p  ! 0.001). Parenchymal hematoma 
rates were 30% (7/23) vs. 8% (7/88), respectively (p = 0.008). 
 Conclusion: CTA identifies a large hyperacute stroke popu-
lation with high mortality and low likelihood for indepen-
dent functional outcome despite early thrombolysis.
 Copyright © 2010 S. Karger AG, Basel
 Introduction
 Some stroke patients will have a poor function -
 al  outcome despite early intravenous (IV) thrombolysis 
with alteplase (rtPA)  [1] . A magnetic resonance imaging 
(MRI)-based malignant profile of early brain ischemia 
has been demonstrated in the Diffusion and Perfusion 
Imaging Evaluation for Understanding Stroke Evolution 
(DEFUSE) study and the Echoplanar Imaging Thrombo-
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 Abstract
 Objective: A malignant profile of early brain ischemia has 
been demonstrated in the Diffusion and Perfusion Imaging 
Evaluation for Understanding Stroke Evolution (DEFUSE) 
 trial. Patients with a malignant profile had a low chance for 
an independent functional outcome despite thrombolysis 
within 3–6 h. We sought to determine whether CT angiogra-
phy (CTA) could identify a malignant imaging profile within 
3 h from symptom onset.  Methods: We studied consecutive 
patients (04/02–09/07) with anterior circulation stroke who 
received CTA before intravenous thrombolysis within 3 h.
We assessed the Alberta Stroke Program Early CT Score
(ASPECTS) on CTA source images (CTASI). Intracranial throm-
bus burden on CTA was assessed with a novel 10-point clot 
burden score (CBS). We analyzed percentages independent 
(modified Rankin Scale score  ^  2) and fatal outcome at 3 
months and parenchymal hematoma rates across catego-
rized combined CTASI-ASPECTS + CBS score groups where 
20 is best and 0 is worst.  Results: We identified 114 patients 
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lytic Evaluation Trial (EPITHET)  [2, 3] . Patients with a 
malignant profile, characterized by a large lesion volume 
on diffusion-weighted imaging (DWI) and/or perfusion 
imaging (PI), had a low chance (17 and 18%, respectively) 
for an independent functional outcome if thrombolyzed 
within 3–6 h from symptom onset.
 Compared with MRI, non-contrast CT (NCCT) is 
more widely available in local general hospitals where 
most stroke patients present  [4] . Quantification of early 
ischemic changes on the pre-treatment NCCT identifies 
patients who are unlikely to achieve an independent 
functional outcome despite thrombolysis within 3 h from 
onset  [1] . However, the percentage of patients who have 
extensive early ischemic changes in NCCT is low and 
their functional outcomes are variable  [1, 5–7] .
 CT angiography (CTA) is increasingly performed in 
the emergency department and can reliably determine 
intracranial vascular status  [8] . More proximal intracra-
nial arterial occlusions are associated with low recanali-
zation rates, likely due to larger thrombus burden  [9–11] . 
Moreover, areas with hypoattenuation on CTA source 
images (CTASI) may delineate brain tissue with ischemic 
damage  [12, 13] . CT perfusion techniques have also been 
evaluated in small series of stroke patients receiving IV 
rtPA  [14] .
 We sought to determine: (1) the frequency of patients 
with acute ischemic stroke who have extensive hypoat-
tenuation on CTASI and/or large intracranial thrombus 
burden on CTA, and (2) whether these patients have a 
poor functional outcome despite IV thrombolysis within 
3 h from symptom onset.
 Methods
 Patients
 We retrospectively studied consecutive (April 2002–Septem-
ber 2007) IV rtPA-treated patients undergoing baseline CTA with 
a final diagnosis of acute anterior circulation ischemic stroke ad-
mitted to Foothills Medical Centre in Calgary. NCCT is the de-
fault imaging modality in patients with suspected acute ischemic 
stroke in our center and followed immediately by CTA prior to IV 
rtPA treatment. CTA was only sporadically performed at the be-
ginning of the study period evolving to frequent use in IV rtPA-
treated patients at the end of the study period. The decision to 
proceed to CTA is at the discretion of the treating stroke neurolo-
gist. For this study we included patients who underwent CTA of 
the circle of Willis before IV thrombolysis with rtPA within 3 h 
from symptom onset. We included subjects who underwent ad-
ditional neurointerventional treatment after IV rtPA treatment in 
the form of intraarterial (IA) thrombolysis and/or mechanical de-
vice use. Exclusion criteria were pre-morbid modified Rankin 
Scale (mRS) score  1 2 and final diagnosis of posterior circulation 
stroke. Clinical baseline variables including the National Institute 
of Health Stroke Scale (NIHSS) score and mRS score are routine-
ly recorded prospectively in the patient record. In cases where 
these scores were unavailable, they were derived retrospectively 
 [15] .
 Functional outcome is recorded prospectively at 3 months in 
a stroke follow-up clinic. Missing functional outcome data were 
imputed from the discharge mRS using the last-score-carried-for-
ward principle. Functional independence was defined as mRS 
scores  ^  2. This study was approved by the local institutional eth-
ics committee.
 Imaging
 Standard non-helical NCCT was performed on a multislice 
CT scanner (GE Medical Systems or Siemens) using 120 kV, 170 
mAs with 5-mm slice thickness. Coverage was from skull base to 
vertex with continuous axial slices parallel to the orbitomeatal 
line. NCCT was followed by CTA with a helical scan technique. 
Acquisitions were obtained after a single bolus IV contrast injec-
tion of 90–120 ml non-ionic contrast media into an antecubital 
vein at 3–5 ml/s. Imaging was auto-triggered by the appearance 
of contrast material in the ascending aorta. Minimum coverage 
was from foramen magnum to centrum semiovale with 0.6- to 
1.25-mm slice thickness. Multiplanar volume-reformatted imag-
es were immediately created by the CT technologist with 2.5- to 
4.0-mm slice thickness in axial, sagittal and coronal planes. This 
image reformatting was typically completed within minutes and 
available for review.
 Follow-up NCCT was performed routinely and follow-up MRI 
as indicated by the treating stroke neurologist. Follow-up imaging 
had to be performed between day 1 and day 7 after symptom on-
set to be assessed for final infarct extension.
 Image Analysis
 We prospectively and independently applied the Alberta 
Stroke Program Early CT Score (ASPECTS) to all baseline NCCT, 
CTASI and follow-up scans by 3-reader consensus with readers 
blinded to clinical information and functional outcome. An AS-
PECT score of 10 indicates a normal scan, a score of 0 indicates 
ischemic changes in the complete middle cerebral artery (MCA) 
territory  [5, 16] . On NCCT, early ischemic changes were defined 
as parenchymal hypoattenuation. On CTASI, regions of relatively 
diminished contrast enhancement were scored as abnormal  [17] . 
On follow-up NCCT, we applied ASPECTS to regions of subacute 
brain infarction. On follow-up MRI we similarly scored hyperin-
tense regions on DWI sequences  [18] . Hemorrhagic transforma-
tion (HT) on follow-up scan was categorized parenchymal hema-
toma (PH) or hemorrhagic infarction (HI) by ECASS criteria  [19] .
 Assessment of Thrombus Extent
 Intracranial thrombus extent on CTA was assessed with a nov-
el clot burden score (CBS)  [20] . CBS allots major intracranial an-
terior circulation arteries 10 points for contrast opacification on 
CTA. Two points each are subtracted for occlusive thrombus pre-
venting contrast opacification in the proximal M1, distal M1 or 
supraclinoid internal carotid artery (ICA) and 1 point each for M2 
branches, A1 or infraclinoid ICA. A score of 10 indicates absence 
of a visible intracranial occlusion on CTA; a score of 0 indicates 
occlusion of all major intracranial anterior circulation arteries.
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 Statistical Analysis
 Data are reported using standard descriptive statistics. We cal-
culated Spearman’s rank correlation coefficient to assess the as-
sociation of the ASPECTS score on CTASI and the CBS score. We 
combined the two scores (CTASI-ASPECTS and CBS) to an addi-
tive score where 20 is best and 0 is worst. A review of the distribu-
tion of the mRS scores according to the combined CTASI-AS-
PECTS + CBS score values suggested that combined score values 
in two categories ( 1 10 and  ^  10) discriminated favorable func-
tional outcome from unfavorable functional outcome and death. 
We analyzed percentages independent functional outcome (mRS 
score  ^  2) and fatal outcome at 3 months and PH rates across di-
chotomized combined CTASI-ASPECTS + CBS score groups ( 1 10 
vs.  ^  10). The distribution of outcomes among these groups was 
compared with the Fisher’s exact test. We performed C-statistics 
to analyze the discriminative ability of baseline imaging scores to 
predict favorable functional outcome and calculated univariate 
Spearman’s rank correlation coefficients to assess the association 
of baseline imaging scores with 3-month mRS scores.
 Results
 Clinical Baseline Characteristics
 From a database containing 1,104 consecutive patients 
who underwent NCCT and CTA for acute cerebrovascular 
ischemia, 167 patients had a final diagnosis of anterior cir-
culation stroke and received IV thrombolysis with rtPA. 
Among these, IV thrombolysis was initiated within 3 h 
from symptom onset and after CTA in 114 patients. These 
were 62 men with a median (interquartile range [IQR]) age 
of 73 years (61–80), baseline NIHSS score of 14 (9–19), on-
set-to-CTA time of 97 min (73–129) and onset-to-rtPA 
time of 129 min (95–152). We treated 22 patients (19%) 
with additional IA thrombolysis (n = 20) or mechanical 
embolectomy with the Mechanical Embolus Removal in 
Cerebral Ischemia (MERCI © ) clot retriever (n = 2).
 Imaging Baseline Characteristics
 The overall median (IQR) ASPECTS on baseline 
NCCT was 8 (6–10) and the median (IQR) ASPECTS on 
baseline CTASI was 7 (5–10). 74 patients (65%) had a de-
monstrable intracranial arterial occlusion on CTA. The 
overall distribution of CBS values was right-skewed with 
a median CBS of 9 (6–10). The CBS showed a moderate 
positive correlation (Spearman’s   = 0.65; p  ! 0.001) with 
the ASPECTS on CTASI, however with a large range of 
CBS scores at a given CTASI-ASPECTS value.
 Patients with Extensive Thrombus Burden and/or 
Extensive Hypoattenuation on CTASI
 Twenty-four patients (21%) had extensive hypoattenu-
ation on CTASI and/or extensive thrombus burden with 
a combined CTASI-ASPECTS + CBS score  ^  10 ( fig. 1 ). 
Baseline characteristics according to the dichotomized 
combined score are summarized in  table 1 . Patients with 
a combined score  ^  10 had higher baseline NIHSS scores 
(p  ! 0.001) and were more frequently treated with addi-
tional IA therapies (p = 0.018). Further clinical baseline 
parameters including the onset-to-CTA time were simi-
lar between both groups. All individual baseline imaging 
a b c
 Fig. 1.   a CTASI demonstrate extensive hypoattenuation. The ASPECTS on CTASI was rated as 3.  b CTA dem-
onstrates occlusion of infraclinoid ICA, supraclinoid ICA and proximal M1-segment. CBS was rated as 5. The 
combined CTASI-ASPECTS + CBS score was 8.  c Follow-up NCCT showed malignant MCA infarction.
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 Table 1.  Clinical baseline characteristics according to dichotomized CTASI-ASPECTS + CBS score groups
 Characteristic  C TASI-ASPECTS + CBS score  p value 
 ≤1 0  >10 
 Patients 24 90 – 
 Age, years, median (IQR) 72 (62–80)  73.5 (60–81) 0.66 
 Male sex, n (%) 10 (42) 52 (58) 0.17 
 NIHSS score, median (IQR) 19 (18–22) 12 (8–17)  <0.001 
 Risk factors, n (%) 
 Diabetes 3 (13) 11 (12) 1 
 Arterial hypertension 9 (38) 54 (60) 0.06 
 Hypercholesterolemia 2 (8) 19 (21) 0.24 
 Atrial fibrillation 5 (21) 16 (18) 0.77 
 Coronary artery disease 6 (25) 24 (27) 1 
 Onset-to-CTA, min, median (IQR) 97.5 (78–120)  94.5 (72–131) 0.78 
 Onset-to-tPA, min, median (IQR)  128.5 (90–152) 129 (96–152) 0.97 
 Additional IA therapy, n (%) 9 (38) 13 (14) 0.018 
 MERCI clot retriever, n (%) 1 (4) 1 (1) 0.38 
 IA rtPA, n (%) 8 (33) 12 (13) 0.033 
 Imaging parameters 
 NCCT-ASPECTS, median (IQR) 5 (3–7) 9 (7–10)  <0.001 
 CTASI-ASPECTS, median (IQR) 2.5 (1–4) 9 (6–10)  <0.001 
 CBS, median (IQR) 6 (4–6) 9 (8–10)  <0.001 
 CTA SI = CT angiography source images; ASPECTS = Alberta Stroke Program Early CT Score; CBS = clot 
burden score; IA = intraarterial; MERCI = Mechanical Embolus Removal in Cerebral Ischemia. 
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 Fig. 2. Clinical outcome at 3 months for categorized CTASI-AS-
PECTS + CBS score groups where 20 is best and 0 is worst. Patients 
with a combined score (CS)  ^  10 are very unlikely to achieve an 
independent functional outcome despite thrombolysis within 3 h 
from symptom onset (numbers of patients in each group: CS 18–
20, n = 42; CS 15–17, n = 26; CS 11–14, n = 22; CS 9–10, n = 12; CS 
6–8, n = 7; CS 0–5, n = 5). 
 Table 2.  Ability of baseline variables to discriminate independent 
and poor functional outcome (defined by area under the receiver 
operator characteristic [ROC] curve) and univariate analysis of 
baseline variables versus final mRS scores (Spearman’s rank cor-
relation coefficient, r)
Area under 
ROC curve
p
value
Correla-
tion coef-
ficient (r)
p
value
 NCCT-ASPECTS  0.63 0.017  –0.25 0.008 
 CTASI-ASPECTS  0.66 0.004  –0.32 0.001 
 CTASI-ASPECTS + CBS  0.69  <0.001  –0.36  <0.001 
 NIHSS score  0.8  <0.001 0.59  <0.001 
 N CCT = Non-contrast CT; CTASI = CT angiography source 
images; ASPECTS = Alberta Stroke Program Early CT Score;
CBS = clot burden score; NIHSS = National Institute of Health 
Stroke Scale. 
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parameters were lower in patients with a combined score 
 ^  10 compared to patients with a combined score  1 10
(p  ! 0.001 for all;  table 1 ).
 Functional Outcome
 At 3 months, 46% (52/114) of patients were function-
ally independent, 36% (41/114) were functionally depen-
dent and 18% (21/114) were deceased.  Figure 2 shows the 
distribution of functional outcomes according to catego-
rized combined CTASI-ASPECTS + CBS score groups. 
Of patients with a combined CTASI-ASPECTS + CBS 
score  ^  10, only 4% (1/24) achieved an independent func-
tional outcome. IV thrombolysis in this patient was start-
ed 90 min from symptom onset. In contrast, mortality in 
this group was 50% (12/24). Of patients with less affected 
scores (combined CTASI-ASPECTS + CBS score 11–20), 
57% (51/90) were functionally independent and 10% 
(9/90) were deceased (Fisher’s exact test; p  ! 0.001).
 C-statistics demonstrated additional discriminative 
ability of the combined CTASI-ASPECTS + CBS score 
compared to the NCCT-ASPECTS and the CTASI-
ASPECTS ( table 2 ). In parallel, univariate analysis dem-
onstrated a better correlation of the combined CTASI-
ASPECTS + CBS score compared to the individual
ASPECTS scores with outcome mRS ( table 2 ). The ability 
of all imaging scores to discriminate independent func-
tional outcome from poor functional outcome was less 
than the discriminative ability of the baseline NIHSS 
score ( table 2 ).
 Comparison of Patients with IV Thrombolysis and 
Combined IV-IA Therapy
 Ninety-two patients were treated with IV thrombolysis 
only and 22 patients received additional IA therapies. Pa-
tients who received additional IA therapies were younger, 
had higher baseline NIHSS scores and more frequently 
had a combined CTASI-ASPECTS + CBS score  ^  10 ( ta-
ble  3 ). Among 92 patients treated with IV thrombolysis 
only, 43 (47%) were functionally independent at 3 months 
compared to 9 of 22 (41%) patients treated with combined 
IV-IA therapies (Fisher’s exact test, p = 0.64). Among pa-
tients with a combined CTASI-ASPECTS + CBS score 
 ^  10, only 1 of 15 (7%) patients treated with IV thrombol-
ysis and none of 9 (0%) patients who received additional IA 
therapies achieved an independent functional outcome.
 Imaging Outcome
 Follow-up images were available for review in 111 pa-
tients. The overall median ASPECTS on follow-up images 
was 7 (4–8). The median ASPECTS on follow-up images 
was lower among patients with a combined score  ^  10 
compared to patients with a combined score  1 10 (2 [0–5] 
vs. 7 [5–9], respectively; p  ! 0.001). Overall, 38 of 111 (34%) 
patients had hemorrhagic transformation on follow-up 
images with PH in 14 patients (13%) and HI in 24 patients 
(22%). PH rates were 30% (7/23) among patients with a 
combined score  ^  10 compared to 8% (7/88) among pa-
tients with a combined score  1 10, respectively (Fisher’s 
exact test; p = 0.008).
 Table 3. C linical and imaging baseline characteristics according to treatment modality
 Characteristic  T reatment modality  p value 
 IV only  IV-IA 
 Patients 92 22 
 Age, years, median (IQR) 74 (62–82) 69 (57–75) 0.018 
 Male sex, n (%) 50 (54) 12 (55) 1 
 NIHSS score, median (IQR) 13 (8–18) 17 (11–21) 0.036 
 Onset-to-CTA, min, median (IQR) 97 (75–131) 86.5 (66–122) 0.31 
 Onset-to-tPA, min, median (IQR)  130 (96–152)  122.5 (88–150) 0.35 
 Imaging parameters 
 NCCT-ASPECTS, median (IQR) 8 (6–10) 7 (5–8) 0.082 
 CTASI-ASPECTS, median (IQR) 8 (6–10) 5 (3–6)  <0.001 
 CBS, median (IQR) 9 (7–10) 6 (5–8)  <0.001 
 Combined score, median (IQR) 17 (14–20) 11 (9–13)  <0.001 
 Combined score ≤10, n (%) 15 (16) 9 (41) 0.018 
 NC CT = Non-contrast CT; CTASI = CT angiography source images; ASPECTS = Alberta Stroke Program 
Early CT Score; CBS = clot burden score; IV = intravenous; IA = intraarterial. 
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 Discussion
 This study demonstrates that rapidly obtainable CT 
angiographic information combining the extent of hy-
poattenuation on CTASI and the intracranial thrombus 
burden on CTA identifies a large (21% of all patients in 
this study) hyperacute stroke population with a high mor-
tality and very low likelihood for an independent func-
tional outcome despite IV thrombolysis or combined IV-
IA therapy initiated within 3 h from symptom onset.
 Extensive early ischemic changes on NCCT indicated 
a low chance of achieving an independent functional out-
come in the NINDS rtPA stroke study and the Canadian 
Alteplase for Stroke Effectiveness Study (CASES)  [1, 7] . 
However, the proportion of patients with extensive early 
ischemic changes, defined as an ASPECTS of  ^  4, was 
only 10.9% (66/608 patients) in the NINDS rtPA stroke 
study and 4.4% (41 of 936 patients) in CASES, respective-
ly  [1, 7] . Moreover, functional outcomes of patients with 
extensive early ischemic changes are variable  [7] .
 CTASI are more sensitive for detection of infarction 
and more accurate for predicting the final infarct size 
and clinical outcome compared with NCCT  [17, 21, 22] . 
Large lesion volumes on CTASI identified patients with 
MCA occlusion who had a poor functional outcome de-
spite recanalization of the MCA within 6 h from symp-
tom onset  [12] . In the same time window (i.e. 6 h from 
onset), the CTASI lesion volume predicted functional 
outcome in patients with MCA M1-segment occlusion 
regardless of the recanalization status in a study by 
Rosenthal et al.  [23] . In our study, the discriminative 
ability of the combined CTASI-ASPECTS + CBS score to 
predict independent functional outcome was improved 
compared to the baseline ASPECTS on NCCT and
CTASI. Of note, the discriminative ability of the baseline 
NIHSS score was higher compared to all baseline imag-
ing scores which is in line with previous data published 
by our group  [7] .
 Time from symptom onset was the only additional in-
dependent predictor of functional outcome among pa-
tients in whom recanalization was achieved in the study 
by Rosenthal et al.  [23] . In line with these results, 1 patient 
in our study achieved an independent functional out-
come despite a low combined score. This patient was 
treated ultra early, i.e. within 90 min from symptom on-
set. The information derived from CTASI may vary. In 
early time windows, CTASI may represent something 
akin to time-to-peak maps with potentially reversible hy-
poattenuation with recanalization  [12] . In later time win-
dows, CTASI may behave more like a cerebral blood vol-
ume parameter map which is highly predictive of the fi-
nal infarct volume  [22] .
 We have recently shown that the intracranial throm-
bus extent, assessed with a novel CBS applied on CTA, 
predicts functional outcome in patients with acute cere-
bral ischemia  [20] . Adopting the same score, Tan et al. 
 [24] have demonstrated lower recanalization rates in pa-
tients with low CBSs (i.e. large thrombus burden) com-
pared to patients with high CBSs (i.e. small thrombus 
burden). As recanalization is unlikely in patients with 
high thrombus burden, the combined assessment of hy-
poattenuation on CTASI (CTASI-ASPECTS) and intra-
cranial thrombus burden on CTA (CBS) may identify pa-
tients who have a poor functional outcome despite early 
IV thrombolysis. Such patients may have similar charac-
teristics as patients with an MRI-based malignant profile 
in the DEFUSE study and the EPITHET trial  [2, 3] . Com-
parison of multimodal stroke MRI and CTA in predict-
ing functional outcome may be possible in ongoing trials 
like the Efficacy and Safety Study of Desmoteplase to 
treat Acute Ischemic Stroke (DIAS-3)  [25] . Moreover, 
such patients may benefit from early aggressive treatment 
paradigms like immediate combined IV-IA therapy as 
currently tested in the Interventional Management of 
Stroke 3 (IMS-3) trial  [26] . A low combined CTASI-AS-
PECTS + CBS score was associated with poor functional 
outcome regardless of the treatment modality (IV throm-
bolysis vs. combined IV-IA therapy) in our study, al-
though the small size of the study hinders definitive con-
clusions.
 Our study is limited by the retrospective study design 
and monocentric data analysis. Moreover, as not all acute 
stroke patients in our center received CTA before throm-
bolytic therapy, results of our study may have been influ-
enced by selection bias. The relatively large number of 
patients who have evidence of an intracranial arterial oc-
clusion on CTA may point to this limitation (i.e. selection 
bias). However, the median NIHSS score in our study (14) 
is similar to the median NIHSS scores of patients in the 
pooled analysis of randomized controlled thrombolysis 
trials and patients in the SITS-MOST registry, suggesting 
that patients in our study represent an average IV rtPA-
treated stroke population  [27, 28] . Due to the retrospec-
tive study design we do not have recanalization data and 
also did not systematically collect information regarding 
hyperdense MCA signs which have been shown to predict 
outcome in large rtPA registries  [29] . The poor function-
al outcome of patients with a low combined score may 
have partially been due to a self-fulfilling prophecy as 
physicians may have limited patient care in early treat-
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ment phases due to expectation of a poor functional out-
come  [30, 31] . We included patients who received addi-
tional IA therapies after initiation of IV thrombolysis. 
However, the decision to treat with additional IA thera-
pies was not influenced by the combined CTASI-AS-
PECTS and CBS score. Moreover, the functional outcome 
in patients with low combined scores was poor in all but 
1 patient regardless of the treatment modality in our 
study.
 In summary, patients with a low combined CTASI-
ASPECTS plus CBS score are unlikely to achieve an inde-
pendent functional outcome despite IV thrombolysis or 
combined IV-IA therapy initiated within 3 h from symp-
tom onset. It needs to be determined which of these pa-
tients benefit from IV thrombolysis, which may be actu-
ally harmed with IV thrombolysis and which may benefit 
from more aggressive treatment paradigms like immedi-
ate combined IV-IA therapy. Ongoing studies like the 
IMS-3 trial may help to answer this question  [26] . We sus-
pect that the answer to this question will vary by stroke 
onset-to-treatment time.
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